Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 101kWORD 18k
16 February 2018
E-000964-18
Question for written answer E-000964-18
to the Commission
Rule 130
Alain Cadec (PPE)

 Subject:  Towards harmonisation of penalties to stamp out falsified medicines in the EU
 Answer in writing 

Directive 2011/62/EU provides for ‘effective, proportionate and dissuasive’ penalties to be applied when falsified medicines are discovered (Article 118a).

However, in practice, those penalties vary considerably from one Member State to another. Prison sentences for falsifying medicines range from 1 to 15 years and fines from EUR 4 300 to 1 000 000. What is more, some countries levy fines for importing and exporting counterfeit products, while others impose only civil penalties for the same wrongdoing.

Will the Commission take measures to make penalties for falsifying medicines more coherent in the EU?

Original language of question: FR 
Last updated: 28 February 2018Legal notice